Results 181 to 190 of about 28,984 (253)

Development and validation of NTCP models for predicting acute esophagitis in carbon ion radiotherapy for thoracic malignancies. [PDF]

BMC Cancer
Li Y, Zhang L, Liu Y, Ma N, Wu KL, Mao J, Chen J.   +6 more
europepmc   +1 more source

Fatal Refractory Radiation-Induced Biliary Stenosis (RIBS) and Liver Abscess Following Carbon-Ion Radiotherapy for Hepatocellular Carcinoma: A Case Report. [PDF]

Cureus
Kidogawa H, Tagami T, Yamayoshi T, Noguchi J, Okamoto K.   +4 more
europepmc   +1 more source

A case of massive hemobilia during plastic stent exchange following distal pancreatectomy with celiac axis resection and carbon-ion radiotherapy. [PDF]

Endoscopy
Soga K, Kuwada M, Shirahashi R, Kobori I, Tamano M.   +4 more
europepmc   +1 more source

Carbon Ion Radiotherapy for Pancreas Cancer

Carbon Ion Radiotherapy for Pancreas Cancer
Adenocarcinoma of the pancreas continues to be a significant source of cancer mortality in Japan, resulting in approximately 19,000 deaths a year. It is the fifth leading cause of cancer-related deaths in Japan, with a less than 5% 5-year expected survival rate1).
openaire  

Assessment of upright immobilization methods for abdominal and head-and-neck cancer treatments in a carbon ion radiotherapy setting. [PDF]

Tech Innov Patient Support Radiat Oncol
Varnava M, Kawashima M, Matsumura A, Oohashi Y, Miyazawa M, Koya J, Yamaguchi N, Ogano T, Tashiro M, Ohno T.   +9 more
europepmc   +1 more source

Carbon-ion radiotherapy achieves outcomes equivalent to surgical resection for hepatocellular carcinoma. [PDF]

Hepatol Commun
Hatanaka T, Shibuya K, Kakizaki S, Hiraoka A, Tada T, Kariyama K, Itobayashi E, Tsuji K, Ishikawa T, Toyoda H, Koshiyama Y, Naganuma A, Miyasaka Y, Kanayama Y, Tanaka K, Tada F, Ohama H, Nouso K, Nakamura S, Kumada T, Ohno T, Real-life Practice Experts for HCC (RELPEC) Study Group.   +21 more
europepmc   +1 more source

Carbon ion radiotherapy at HIMAC-NIRS

Carbon ion radiotherapy at HIMAC-NIRS
In 1994, carbon ion radiotherapy was begun at the NIRS (National Institute of Radiological Sciences) using HIMAC (Heavy-Ion Medical Accelerator in Chiba), which was the world's first heavy ion accelerator complex dedicated to medical use in a hospital environment.
openaire  

Carbon-Ion Radiotherapy for Prostate Cancer in Patients with a History of Surgery for Benign Prostatic Hyperplasia. [PDF]

Cancers (Basel)
Okato A, Miura K, Yamaguchi T, Nakajima M, Makishima H, Utsumi T, Akakura K, Suzuki H, Wakatsuki M, Tsuji H, Ichikawa T, Ishikawa H.   +11 more
europepmc   +1 more source

Assessment of the impact of CT scan protocols on carbon ion radiotherapy treatment planning. [PDF]

J Appl Clin Med Phys
Miyasaka Y, Souda H, Hagiwara Y, Akamatsu H, Harada M, Kaneko T, Chai H, Ishizawa M, Sato H, Koto M, Iwai T.   +10 more
europepmc   +1 more source

Clinical advantages of carbon-ion radiotherapy

Clinical advantages of carbon-ion radiotherapy
Carbon-ion radiotherapy(C-ion RT)possesses physical and biological advantages. It was started at NIRS in 1994 using the Heavy Ion Medical Accelerator in Chiba(HIMAC); since then more than 50 protocol studies have been conducted on almost 4000 patients with avariety of tumors.
openaire